IBDEI0AF ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13911,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,13912,0)
 ;;=616.0^^86^757^18
 ;;^UTILITY(U,$J,358.3,13912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13912,1,3,0)
 ;;=3^616.0
 ;;^UTILITY(U,$J,358.3,13912,1,4,0)
 ;;=4^Cervicitis
 ;;^UTILITY(U,$J,358.3,13912,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,13913,0)
 ;;=078.10^^86^757^45
 ;;^UTILITY(U,$J,358.3,13913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13913,1,3,0)
 ;;=3^078.10
 ;;^UTILITY(U,$J,358.3,13913,1,4,0)
 ;;=4^Genital Warts
 ;;^UTILITY(U,$J,358.3,13913,2)
 ;;=^295787
 ;;^UTILITY(U,$J,358.3,13914,0)
 ;;=625.3^^86^757^28
 ;;^UTILITY(U,$J,358.3,13914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13914,1,3,0)
 ;;=3^625.3
 ;;^UTILITY(U,$J,358.3,13914,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,13914,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,13915,0)
 ;;=625.0^^86^757^29
 ;;^UTILITY(U,$J,358.3,13915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13915,1,3,0)
 ;;=3^625.0
 ;;^UTILITY(U,$J,358.3,13915,1,4,0)
 ;;=4^Dyspareunia
 ;;^UTILITY(U,$J,358.3,13915,2)
 ;;=^37604
 ;;^UTILITY(U,$J,358.3,13916,0)
 ;;=788.1^^86^757^33
 ;;^UTILITY(U,$J,358.3,13916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13916,1,3,0)
 ;;=3^788.1
 ;;^UTILITY(U,$J,358.3,13916,1,4,0)
 ;;=4^Dysuria
 ;;^UTILITY(U,$J,358.3,13916,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,13917,0)
 ;;=789.30^^86^757^67
 ;;^UTILITY(U,$J,358.3,13917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13917,1,3,0)
 ;;=3^789.30
 ;;^UTILITY(U,$J,358.3,13917,1,4,0)
 ;;=4^Pelvic Abdominal Mass
 ;;^UTILITY(U,$J,358.3,13917,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,13918,0)
 ;;=614.9^^86^757^68
 ;;^UTILITY(U,$J,358.3,13918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13918,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,13918,1,4,0)
 ;;=4^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,13918,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,13919,0)
 ;;=218.9^^86^757^90
 ;;^UTILITY(U,$J,358.3,13919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13919,1,3,0)
 ;;=3^218.9
 ;;^UTILITY(U,$J,358.3,13919,1,4,0)
 ;;=4^Uterine Fibroids
 ;;^UTILITY(U,$J,358.3,13919,2)
 ;;=^68944
 ;;^UTILITY(U,$J,358.3,13920,0)
 ;;=618.1^^86^757^91
 ;;^UTILITY(U,$J,358.3,13920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13920,1,3,0)
 ;;=3^618.1
 ;;^UTILITY(U,$J,358.3,13920,1,4,0)
 ;;=4^Uterine Prolapse
 ;;^UTILITY(U,$J,358.3,13920,2)
 ;;=^124773
 ;;^UTILITY(U,$J,358.3,13921,0)
 ;;=112.1^^86^757^93
 ;;^UTILITY(U,$J,358.3,13921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13921,1,3,0)
 ;;=3^112.1
 ;;^UTILITY(U,$J,358.3,13921,1,4,0)
 ;;=4^Vaginitis, Candidal
 ;;^UTILITY(U,$J,358.3,13921,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,13922,0)
 ;;=099.53^^86^757^96
 ;;^UTILITY(U,$J,358.3,13922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13922,1,3,0)
 ;;=3^099.53
 ;;^UTILITY(U,$J,358.3,13922,1,4,0)
 ;;=4^Vaginits, Chlamydial
 ;;^UTILITY(U,$J,358.3,13922,2)
 ;;=^293988
 ;;^UTILITY(U,$J,358.3,13923,0)
 ;;=131.01^^86^757^94
 ;;^UTILITY(U,$J,358.3,13923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13923,1,3,0)
 ;;=3^131.01
 ;;^UTILITY(U,$J,358.3,13923,1,4,0)
 ;;=4^Vaginitis, Trichonomal
 ;;^UTILITY(U,$J,358.3,13923,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,13924,0)
 ;;=592.0^^86^757^52
 ;;^UTILITY(U,$J,358.3,13924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13924,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,13924,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,13924,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,13925,0)
 ;;=627.2^^86^757^87
 ;;^UTILITY(U,$J,358.3,13925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13925,1,3,0)
 ;;=3^627.2
 ;;^UTILITY(U,$J,358.3,13925,1,4,0)
 ;;=4^Symptomatic Menopause
 ;;^UTILITY(U,$J,358.3,13925,2)
 ;;=^328735
 ;;^UTILITY(U,$J,358.3,13926,0)
 ;;=622.10^^86^757^30
 ;;^UTILITY(U,$J,358.3,13926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13926,1,3,0)
 ;;=3^622.10
 ;;^UTILITY(U,$J,358.3,13926,1,4,0)
 ;;=4^Dysplasia of Cervix
 ;;^UTILITY(U,$J,358.3,13926,2)
 ;;=^331546
 ;;^UTILITY(U,$J,358.3,13927,0)
 ;;=622.11^^86^757^31
 ;;^UTILITY(U,$J,358.3,13927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13927,1,3,0)
 ;;=3^622.11
 ;;^UTILITY(U,$J,358.3,13927,1,4,0)
 ;;=4^Dysplasia of Cervix, Mild
 ;;^UTILITY(U,$J,358.3,13927,2)
 ;;=^331547
 ;;^UTILITY(U,$J,358.3,13928,0)
 ;;=622.12^^86^757^32
 ;;^UTILITY(U,$J,358.3,13928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13928,1,3,0)
 ;;=3^622.12
 ;;^UTILITY(U,$J,358.3,13928,1,4,0)
 ;;=4^Dysplasia of Cervix, Moderate
 ;;^UTILITY(U,$J,358.3,13928,2)
 ;;=^331548
 ;;^UTILITY(U,$J,358.3,13929,0)
 ;;=V72.40^^86^757^74
 ;;^UTILITY(U,$J,358.3,13929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13929,1,3,0)
 ;;=3^V72.40
 ;;^UTILITY(U,$J,358.3,13929,1,4,0)
 ;;=4^Pregnancy Exam/Test
 ;;^UTILITY(U,$J,358.3,13929,2)
 ;;=^331589
 ;;^UTILITY(U,$J,358.3,13930,0)
 ;;=V67.01^^86^757^66
 ;;^UTILITY(U,$J,358.3,13930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13930,1,3,0)
 ;;=3^V67.01
 ;;^UTILITY(U,$J,358.3,13930,1,4,0)
 ;;=4^Pap Smear Following Surgery
 ;;^UTILITY(U,$J,358.3,13930,2)
 ;;=^322078
 ;;^UTILITY(U,$J,358.3,13931,0)
 ;;=627.4^^86^757^12
 ;;^UTILITY(U,$J,358.3,13931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13931,1,3,0)
 ;;=3^627.4
 ;;^UTILITY(U,$J,358.3,13931,1,4,0)
 ;;=4^Artificial Menopause-Symptomatic
 ;;^UTILITY(U,$J,358.3,13931,2)
 ;;=^328736
 ;;^UTILITY(U,$J,358.3,13932,0)
 ;;=793.80^^86^757^3
 ;;^UTILITY(U,$J,358.3,13932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13932,1,3,0)
 ;;=3^793.80
 ;;^UTILITY(U,$J,358.3,13932,1,4,0)
 ;;=4^Abnormal Mammogram
 ;;^UTILITY(U,$J,358.3,13932,2)
 ;;=^323613
 ;;^UTILITY(U,$J,358.3,13933,0)
 ;;=V76.47^^86^757^83
 ;;^UTILITY(U,$J,358.3,13933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13933,1,3,0)
 ;;=3^V76.47
 ;;^UTILITY(U,$J,358.3,13933,1,4,0)
 ;;=4^Special Screening for vaginal Malignant Neoplasms
 ;;^UTILITY(U,$J,358.3,13933,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,13934,0)
 ;;=V45.77^^86^757^8
 ;;^UTILITY(U,$J,358.3,13934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13934,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,13934,1,4,0)
 ;;=4^Acquired Absence of Uterus
 ;;^UTILITY(U,$J,358.3,13934,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,13935,0)
 ;;=233.1^^86^757^16
 ;;^UTILITY(U,$J,358.3,13935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13935,1,3,0)
 ;;=3^233.1
 ;;^UTILITY(U,$J,358.3,13935,1,4,0)
 ;;=4^CA in Situ (Sev. Dysplasia)
 ;;^UTILITY(U,$J,358.3,13935,2)
 ;;=^267736
 ;;^UTILITY(U,$J,358.3,13936,0)
 ;;=789.00^^86^757^1
 ;;^UTILITY(U,$J,358.3,13936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13936,1,3,0)
 ;;=3^789.00
 ;;^UTILITY(U,$J,358.3,13936,1,4,0)
 ;;=4^Abdom Pain, Unsp Site
 ;;^UTILITY(U,$J,358.3,13936,2)
 ;;=^303317
 ;;^UTILITY(U,$J,358.3,13937,0)
 ;;=795.09^^86^757^2
 ;;^UTILITY(U,$J,358.3,13937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13937,1,3,0)
 ;;=3^795.09
 ;;^UTILITY(U,$J,358.3,13937,1,4,0)
 ;;=4^Abn Pap Cervix HPV NEC
 ;;^UTILITY(U,$J,358.3,13937,2)
 ;;=^331974
 ;;^UTILITY(U,$J,358.3,13938,0)
 ;;=V45.77^^86^757^7
 ;;^UTILITY(U,$J,358.3,13938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13938,1,3,0)
 ;;=3^V45.77
 ;;^UTILITY(U,$J,358.3,13938,1,4,0)
 ;;=4^Acq Absence Org,Genitals
 ;;^UTILITY(U,$J,358.3,13938,2)
 ;;=^322067
 ;;^UTILITY(U,$J,358.3,13939,0)
 ;;=215.9^^86^757^13
 ;;^UTILITY(U,$J,358.3,13939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13939,1,3,0)
 ;;=3^215.9
 ;;^UTILITY(U,$J,358.3,13939,1,4,0)
 ;;=4^Ben Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,13939,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,13940,0)
 ;;=221.2^^86^757^14
 ;;^UTILITY(U,$J,358.3,13940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13940,1,3,0)
 ;;=3^221.2
 ;;^UTILITY(U,$J,358.3,13940,1,4,0)
 ;;=4^Benign Neoplasm Vulva
 ;;^UTILITY(U,$J,358.3,13940,2)
 ;;=^267650
 ;;^UTILITY(U,$J,358.3,13941,0)
 ;;=795.05^^86^757^17
 ;;^UTILITY(U,$J,358.3,13941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13941,1,3,0)
 ;;=3^795.05
 ;;^UTILITY(U,$J,358.3,13941,1,4,0)
 ;;=4^Cervical (HPV) DNA POS
 ;;^UTILITY(U,$J,358.3,13941,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,13942,0)
 ;;=701.0^^86^757^20
 ;;^UTILITY(U,$J,358.3,13942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13942,1,3,0)
 ;;=3^701.0
 ;;^UTILITY(U,$J,358.3,13942,1,4,0)
 ;;=4^Circumscribe Scleroderma
 ;;^UTILITY(U,$J,358.3,13942,2)
 ;;=^108577
 ;;^UTILITY(U,$J,358.3,13943,0)
 ;;=618.01^^86^757^26
 ;;^UTILITY(U,$J,358.3,13943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13943,1,3,0)
 ;;=3^618.01
 ;;^UTILITY(U,$J,358.3,13943,1,4,0)
 ;;=4^Cystocele, Midline
 ;;^UTILITY(U,$J,358.3,13943,2)
 ;;=^331534
 ;;^UTILITY(U,$J,358.3,13944,0)
 ;;=621.30^^86^757^35
 ;;^UTILITY(U,$J,358.3,13944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13944,1,3,0)
 ;;=3^621.30
 ;;^UTILITY(U,$J,358.3,13944,1,4,0)
 ;;=4^Endometrial Hyperplas NOS
 ;;^UTILITY(U,$J,358.3,13944,2)
 ;;=^331542
 ;;^UTILITY(U,$J,358.3,13945,0)
 ;;=626.2^^86^757^38
 ;;^UTILITY(U,$J,358.3,13945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13945,1,3,0)
 ;;=3^626.2
 ;;^UTILITY(U,$J,358.3,13945,1,4,0)
 ;;=4^Excessive Menstrauation
 ;;^UTILITY(U,$J,358.3,13945,2)
 ;;=^75895
 ;;^UTILITY(U,$J,358.3,13946,0)
 ;;=V16.41^^86^757^39
 ;;^UTILITY(U,$J,358.3,13946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13946,1,3,0)
 ;;=3^V16.41
 ;;^UTILITY(U,$J,358.3,13946,1,4,0)
 ;;=4^Fam HX, Malig Neopl of Ovary
 ;;^UTILITY(U,$J,358.3,13946,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,13947,0)
 ;;=625.6^^86^757^40
 ;;^UTILITY(U,$J,358.3,13947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13947,1,3,0)
 ;;=3^625.6
 ;;^UTILITY(U,$J,358.3,13947,1,4,0)
 ;;=4^Fem Stress Incontinence
 ;;^UTILITY(U,$J,358.3,13947,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,13948,0)
 ;;=V53.99^^86^757^43
 ;;^UTILITY(U,$J,358.3,13948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13948,1,3,0)
 ;;=3^V53.99
 ;;^UTILITY(U,$J,358.3,13948,1,4,0)
 ;;=4^Fit/Adjust Device NEC
 ;;^UTILITY(U,$J,358.3,13948,2)
 ;;=^329974
 ;;^UTILITY(U,$J,358.3,13949,0)
 ;;=611.71^^86^757^54
 ;;^UTILITY(U,$J,358.3,13949,1,0)
 ;;=^358.31IA^4^2
